Fisher & Paykel Healthcare (FPH) Stock Overview
Designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for FPH from our risk checks.
FPH Community Fair Values
Create NarrativeSee what 6 others think this stock is worth. Follow their fair value or set your own to get alerts.
Fisher & Paykel Healthcare Corporation Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | NZ$34.72 |
| 52 Week High | NZ$35.76 |
| 52 Week Low | NZ$26.70 |
| Beta | 0.74 |
| 1 Month Change | 5.63% |
| 3 Month Change | 11.78% |
| 1 Year Change | 22.86% |
| 3 Year Change | 90.98% |
| 5 Year Change | 29.02% |
| Change since IPO | 1,329.28% |
Recent News & Updates
Recent updates
Shareholder Returns
| FPH | AU Medical Equipment | AU Market | |
|---|---|---|---|
| 7D | 7.7% | -0.6% | 1.8% |
| 1Y | 22.9% | -12.5% | 8.4% |
Return vs Industry: FPH exceeded the Australian Medical Equipment industry which returned -11.1% over the past year.
Return vs Market: FPH exceeded the Australian Market which returned 7.8% over the past year.
Price Volatility
| FPH volatility | |
|---|---|
| FPH Average Weekly Movement | 4.4% |
| Medical Equipment Industry Average Movement | 11.6% |
| Market Average Movement | 9.5% |
| 10% most volatile stocks in AU Market | 17.7% |
| 10% least volatile stocks in AU Market | 3.9% |
Stable Share Price: FPH has not had significant price volatility in the past 3 months compared to the Australian market.
Volatility Over Time: FPH's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1934 | 7,412 | Lewis Gradon | www.fphcare.com |
Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems in North America, Europe, the Asia Pacific, and internationally. It provides its products for use in acute and chronic respiratory care, and surgery, as well as the treatment of obstructive sleep apnea (OSA) in the home and hospital. The company also offers adult respiratory products, including airvo system, optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation.
Fisher & Paykel Healthcare Corporation Limited Fundamentals Summary
| FPH fundamental statistics | |
|---|---|
| Market cap | AU$20.18b |
| Earnings (TTM) | AU$350.29m |
| Revenue (TTM) | AU$1.88b |
Is FPH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| FPH income statement (TTM) | |
|---|---|
| Revenue | NZ$2.02b |
| Cost of Revenue | NZ$750.10m |
| Gross Profit | NZ$1.27b |
| Other Expenses | NZ$893.70m |
| Earnings | NZ$377.20m |
Last Reported Earnings
Mar 31, 2025
Next Earnings Date
Nov 26, 2025
| Earnings per share (EPS) | 0.64 |
| Gross Margin | 62.88% |
| Net Profit Margin | 18.66% |
| Debt/Equity Ratio | 3.4% |
How did FPH perform over the long term?
See historical performance and comparisonDividends
Does FPH pay a reliable dividends?
See FPH dividend history and benchmarks| Fisher & Paykel Healthcare dividend dates | |
|---|---|
| Ex Dividend Date | Jun 23 2025 |
| Dividend Pay Date | Jul 04 2025 |
| Days until Ex dividend | 18 days |
| Days until Dividend pay date | 29 days |
Does FPH pay a reliable dividends?
See FPH dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/06/05 08:33 |
| End of Day Share Price | 2025/06/05 00:00 |
| Earnings | 2025/03/31 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Fisher & Paykel Healthcare Corporation Limited is covered by 25 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Saul Hadassin | Barrenjoey Markets Pty Limited |
| Lyanne Harrison | BofA Global Research |
| Mathieu Chevrier | Citigroup Inc |